David C. Gale
Nessuna posizione attualmente
Storia della carriera di David C. Gale
Precedenti posizioni note di David C. Gale
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INTERSECT ENT, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2007 | 01/08/2009 |
| ARTIVION, INC. | Direttore Tecnico/Scientifico/R&S | 06/01/2012 | - |
Formazione di David C. Gale
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Borsa valori
- Insiders
- David C. Gale
- Esperienza
